Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0180 Transporter Info | ||||
Gene Name | SLC25A20 | ||||
Transporter Name | Carnitine/acylcarnitine translocase | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 1.00E-02; Z-score: -1.99E+00 | ||
Methylation in Case |
5.24E-01 (Median) | Methylation in Control | 6.16E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in bladder cancer | [ 1 ] | |||
Location |
TSS200 (cg25624927) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.32E+00 | Statistic Test | p-value: 2.23E-02; Z-score: -2.90E+00 | ||
Methylation in Case |
1.86E-02 (Median) | Methylation in Control | 4.31E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in bladder cancer | [ 1 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.51E+00 | Statistic Test | p-value: 8.68E-07; Z-score: -4.34E+00 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in bladder cancer | [ 1 ] | |||
Location |
Body (cg14014369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.41E-02; Z-score: -1.52E+00 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 9.86E-09; Z-score: -1.78E+00 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg04492826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.57E-02; Z-score: -3.36E-01 | ||
Methylation in Case |
9.11E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg22919115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 1.55E-02; Z-score: 6.30E-01 | ||
Methylation in Case |
3.85E-01 (Median) | Methylation in Control | 3.49E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in breast cancer | [ 2 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 5.36E-09; Z-score: -1.26E+00 | ||
Methylation in Case |
4.71E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A20 in breast cancer | [ 2 ] | |||
Location |
Body (cg01191114) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 4.29E-02; Z-score: 2.93E-01 | ||
Methylation in Case |
1.08E-02 (Median) | Methylation in Control | 9.54E-03 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 1.56E-09; Z-score: -2.70E+00 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg04492826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.05E-06; Z-score: -1.56E+00 | ||
Methylation in Case |
9.73E-01 (Median) | Methylation in Control | 9.79E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg15588941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 8.83E-06; Z-score: -2.42E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 8.21E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg18630857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 2.25E-02; Z-score: 5.86E-01 | ||
Methylation in Case |
3.47E-02 (Median) | Methylation in Control | 3.21E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg20495332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.58E+00 | Statistic Test | p-value: 4.58E-11; Z-score: -2.32E+00 | ||
Methylation in Case |
3.52E-02 (Median) | Methylation in Control | 9.07E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.43E+00 | Statistic Test | p-value: 5.89E-07; Z-score: -2.69E+00 | ||
Methylation in Case |
4.30E-01 (Median) | Methylation in Control | 6.15E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A20 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg01191114) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 5.95E-06; Z-score: 1.01E+00 | ||
Methylation in Case |
1.88E-02 (Median) | Methylation in Control | 1.66E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg18710929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.24E+00 | Statistic Test | p-value: 4.12E-06; Z-score: 1.48E+01 | ||
Methylation in Case |
3.85E-01 (Median) | Methylation in Control | 9.08E-02 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg27037018) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.88E+00 | Statistic Test | p-value: 7.90E-08; Z-score: 5.78E+00 | ||
Methylation in Case |
5.95E-01 (Median) | Methylation in Control | 1.53E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg17037355) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.27E+00 | Statistic Test | p-value: 9.49E-07; Z-score: 3.93E+00 | ||
Methylation in Case |
6.14E-01 (Median) | Methylation in Control | 4.84E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 4.43E-06; Z-score: 2.44E+00 | ||
Methylation in Case |
5.32E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg21017569) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 6.67E-06; Z-score: 1.08E+00 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 8.37E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg26494252) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.32E-03; Z-score: -8.01E-01 | ||
Methylation in Case |
6.17E-01 (Median) | Methylation in Control | 6.31E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A20 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg09283154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.76E+00 | Statistic Test | p-value: 1.44E-08; Z-score: 4.86E+00 | ||
Methylation in Case |
4.81E-01 (Median) | Methylation in Control | 2.73E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 5.10E-08; Z-score: 1.57E+00 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 5.53E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg15588941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.09E-06; Z-score: 1.23E+00 | ||
Methylation in Case |
6.84E-01 (Median) | Methylation in Control | 6.09E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 1.51E-03; Z-score: -8.36E-01 | ||
Methylation in Case |
2.05E-01 (Median) | Methylation in Control | 2.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 2.69E-04; Z-score: -3.79E+00 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 6.67E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg20963030) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.49E-03; Z-score: 9.23E-01 | ||
Methylation in Case |
7.83E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg20822540) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.99E-02; Z-score: -7.43E-01 | ||
Methylation in Case |
7.13E-01 (Median) | Methylation in Control | 7.97E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg10782875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.23E-02; Z-score: -5.18E-01 | ||
Methylation in Case |
9.73E-02 (Median) | Methylation in Control | 1.09E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg03993154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 3.38E-02; Z-score: -4.56E-01 | ||
Methylation in Case |
1.20E-01 (Median) | Methylation in Control | 1.41E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.38E-01 | Statistic Test | p-value: 4.40E-03; Z-score: 5.32E-01 | ||
Methylation in Case |
-2.61E+00 (Median) | Methylation in Control | -2.78E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in panic disorder | [ 8 ] | |||
Location |
TSS200 (cg15588941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 1.87E-02; Z-score: 4.25E-01 | ||
Methylation in Case |
1.13E+00 (Median) | Methylation in Control | 9.62E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in panic disorder | [ 8 ] | |||
Location |
TSS200 (cg18630857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.89E-01 | Statistic Test | p-value: 3.25E-02; Z-score: 3.43E-01 | ||
Methylation in Case |
-5.01E+00 (Median) | Methylation in Control | -5.07E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg05964212) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.16E-02; Z-score: -4.50E-01 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 8.77E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg25624927) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.00E-04; Z-score: -1.06E+00 | ||
Methylation in Case |
8.63E-02 (Median) | Methylation in Control | 1.09E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg18630857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 5.04E-03; Z-score: -5.66E-01 | ||
Methylation in Case |
9.29E-02 (Median) | Methylation in Control | 1.01E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg20495332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 1.65E-03; Z-score: -1.30E+00 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 1.57E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in colorectal cancer | [ 10 ] | |||
Location |
TSS200 (cg22919115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 2.95E-05; Z-score: -1.12E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 5.39E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in colorectal cancer | [ 10 ] | |||
Location |
TSS200 (cg15588941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.53E-03; Z-score: -5.55E-01 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 7.35E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in colorectal cancer | [ 10 ] | |||
Location |
Body (cg14014369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.43E-05; Z-score: -1.09E+00 | ||
Methylation in Case |
8.71E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in colorectal cancer | [ 10 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.25E-02; Z-score: -5.05E-01 | ||
Methylation in Case |
4.33E-01 (Median) | Methylation in Control | 4.92E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A20 in colorectal cancer | [ 10 ] | |||
Location |
Body (cg20495332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.69E-02; Z-score: 4.68E-01 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in HIV infection | [ 11 ] | |||
Location |
TSS200 (cg22919115) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 3.29E-04; Z-score: -1.20E+00 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 4.73E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in HIV infection | [ 11 ] | |||
Location |
TSS200 (cg15588941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 4.74E-04; Z-score: -1.10E+00 | ||
Methylation in Case |
6.12E-01 (Median) | Methylation in Control | 6.69E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in HIV infection | [ 11 ] | |||
Location |
Body (cg20495332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 2.40E-03; Z-score: -8.67E-01 | ||
Methylation in Case |
6.42E-02 (Median) | Methylation in Control | 7.66E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A20 in HIV infection | [ 11 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 4.75E-02; Z-score: 4.96E-01 | ||
Methylation in Case |
3.11E-01 (Median) | Methylation in Control | 2.83E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg25624927) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.09E-02; Z-score: -2.53E-01 | ||
Methylation in Case |
2.09E-02 (Median) | Methylation in Control | 2.34E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in systemic lupus erythematosus | [ 12 ] | |||
Location |
Body (cg14014369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.91E-02; Z-score: -1.18E-01 | ||
Methylation in Case |
7.59E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.61E+00 | Statistic Test | p-value: 4.38E-05; Z-score: 1.10E+00 | ||
Methylation in Case |
5.23E-01 (Median) | Methylation in Control | 3.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg01191114) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 5.24E-05; Z-score: 7.67E-01 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 9.66E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A20 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg14014369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.20E-02; Z-score: 2.98E-01 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Celiac disease |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in celiac disease | [ 14 ] | |||
Location |
Body (cg00948664) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.49E+00 | Statistic Test | p-value: 3.46E-02; Z-score: 9.10E-01 | ||
Methylation in Case |
1.51E-01 (Median) | Methylation in Control | 1.02E-01 (Median) | ||
Studied Phenotype |
Celiac disease [ ICD-11: DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A20 in prostate cancer | [ 15 ] | |||
Location |
Body (cg16680214) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.60E+00 | Statistic Test | p-value: 3.74E-02; Z-score: -1.78E+00 | ||
Methylation in Case |
1.41E-01 (Median) | Methylation in Control | 2.25E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A20 in prostate cancer | [ 15 ] | |||
Location |
Body (cg11624345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 4.01E-02; Z-score: 1.90E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Oligodendroglial tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC25A20 in oligodendroglial tumour than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglial tumour [ICD-11:2A00.Y1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.32E-08; Fold-change: 0.202539012; Z-score: 34.6775561 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC25A20 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 6.89E-53; Fold-change: 0.383417074; Z-score: 12.33871769 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-3156 directly targets SLC25A20 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3156 | miRNA Mature ID | miR-3156-5p | ||
miRNA Sequence |
AAAGAUCUGGAAGUGGGAGACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-3658 directly targets SLC25A20 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3658 | miRNA Mature ID | miR-3658 | ||
miRNA Sequence |
UUUAAGAAAACACCAUGGAGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-500a directly targets SLC25A20 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-500a | miRNA Mature ID | miR-500a-5p | ||
miRNA Sequence |
UAAUCCUUGCUACCUGGGUGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-501 directly targets SLC25A20 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-501 | miRNA Mature ID | miR-501-5p | ||
miRNA Sequence |
AAUCCUUUGUCCCUGGGUGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-7856 directly targets SLC25A20 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7856 | miRNA Mature ID | miR-7856-5p | ||
miRNA Sequence |
UUUUAAGGACACUGAGGGAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.